| (210) | Number of the EPO application | 24156902 |
| (220) | Filing date of the EPO application | 2019.05.10 |
| (80) | EPO patent specification publication (B) | EPB nr. 48/2025, 2025.11.26 |
| (110) | EPO patent number | 4364724 |
| (21) | Number of the application | e 2025 0237 |
| (71) | Name(s) of applicant(s), code of the country | Regeneron Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | GRAHAM Kenneth S., US;
WADHWA Saurabh, US; |
| (73) | Name(s) of owner(s), code of the country | REGENERON Pharmaceuticals Inc., US; |
| (54) | Title of the invention | HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING FORMULATIONS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/00 (2006.01.01); A61K 38/17 (2006.01.01); A61K 47/22 (2006.01.01); A61P 27/02 (2006.01.01); A61K 47/26 (2006.01.01); A61K 9/08 (2006.01.01) |
| (52) | Cooperative Patent Classification | A61P 27/02 (EP); A61K 9/0048 (EP); A61K 9/08 (EP); A61K 38/179 (EP); A61K 39/39591 (EP); A61K 47/183 (EP); A61K 47/22 (EP); A61K 47/26 (EP); C07K 14/71 (EP); C07K 16/22 (EP) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2025.04.30 |
| (30) | Priority | 201862669506 P, 2018.05.10, US; 201862752127 P, 2018.10.29, US; 201862769876 P, 2018.11.20, US; 201962813882 P, 2019.03.05, US |